Clinical Trial Update: PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal Toxicity [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the preventive efficacy and safety of rebamipide for NSAID-induced mucosal toxicity in rheumatoid arthritis and related diseases has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis
• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Mucosta (rebamipide)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Rheumatoid Arthritis, Osteoarthritis | Phase 3 | Status: COMPLETED